A detailed history of Pro Share Advisors LLC transactions in Ab Cellera Biologics Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 17,412 shares of ABCL stock, worth $51,365. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17,412
Previous 18,152 4.08%
Holding current value
$51,365
Previous $53,000 15.09%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$2.39 - $3.49 $1,768 - $2,582
-740 Reduced 4.08%
17,412 $45,000
Q2 2024

Aug 13, 2024

SELL
$2.73 - $4.73 $6,459 - $11,191
-2,366 Reduced 11.53%
18,152 $53,000
Q1 2024

May 08, 2024

BUY
$4.29 - $5.97 $8,485 - $11,808
1,978 Added 10.67%
20,518 $92,000
Q4 2023

Feb 14, 2024

SELL
$3.91 - $5.93 $1,470 - $2,229
-376 Reduced 1.99%
18,540 $105,000
Q3 2023

Nov 13, 2023

BUY
$4.6 - $7.95 $1,076 - $1,860
234 Added 1.25%
18,916 $87,000
Q2 2023

Aug 10, 2023

SELL
$5.66 - $7.59 $145,111 - $194,592
-25,638 Reduced 57.85%
18,682 $120,000
Q1 2023

May 11, 2023

SELL
$7.31 - $11.18 $43,779 - $66,957
-5,989 Reduced 11.9%
44,320 $334,000
Q4 2022

Feb 02, 2023

BUY
$9.48 - $14.52 $33,132 - $50,747
3,495 Added 7.47%
50,309 $509,000
Q3 2022

Nov 04, 2022

BUY
$9.2 - $13.68 $12,797 - $19,028
1,391 Added 3.06%
46,814 $463,000
Q2 2022

Aug 01, 2022

BUY
$5.72 - $10.65 $91,176 - $169,761
15,940 Added 54.07%
45,423 $484,000
Q1 2022

May 10, 2022

SELL
$7.46 - $14.14 $75,868 - $143,803
-10,170 Reduced 25.65%
29,483 $287,000
Q4 2021

Feb 08, 2022

BUY
$12.99 - $17.73 $515,092 - $703,047
39,653 New
39,653 $567,000

Others Institutions Holding ABCL

About AbCellera Biologics Inc.


  • Ticker ABCL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 285,139,008
  • Market Cap $841M
  • Description
  • AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...
More about ABCL
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.